Conmed (CNMD) Change in Accured Expenses (2010 - 2026)

Conmed (CNMD) has 17 years of Change in Accured Expenses data on file, last reported at $9.4 million in Q2 2026.

• Quarterly Change in Accured Expenses rose 165.74% year-over-year to $9.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.5 million (up 39.51% YoY) and the FY2025 annual result came in at $14.9 million, up 451.06% from the prior year.
• Change in Accured Expenses improved to $9.4 million in Q2 2026, from -$21.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $14.1 million in Q3 2023 to a low of -$21.2 million in Q1 2026.
• A 5-year average of $245333.3 and a median of $3.9 million in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 1367.89% — and 2025, when it slumped 345.28%.
• Tracing CNMD's Change in Accured Expenses over 5 years: stood at -$707000.0 in 2022, then surged by 1367.89% to $9.0 million in 2023, then slumped by 57.44% to $3.8 million in 2024, then soared by 55.26% to $5.9 million in 2025, then soared by 59.5% to $9.4 million in 2026.
• The last three Change in Accured Expenses figures came in at $9.4 million (Q2 2026), -$21.2 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.